Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Nylon Membrane Filter Produces Highly Effective Reduction of Endotoxins

Published: Thursday, October 03, 2013
Last Updated: Thursday, October 03, 2013
Bookmark and Share
Hydrofil HTZ from Porvair Filtration Group.

Porvair Filtration Group has introduced Hydrofil HTZ - an innovative dual 0.2µm membrane sterilization filter cartridge that incorporates a pharmaceutical grade, positively charged Nylon 6,6 membrane.

The positive zeta-potential of the nylon membrane enables highly effective reduction of most endotoxins derived from bacteria which typically have a negative charge in water. The dual membrane structure results in a significant increase in the endotoxin adsorption capacity of the filter.

Applications for Hydrofil HTZ include GMP pharmaceutical grade water systems where endotoxins levels need to be kept below Limulus Amebocyte Lysate (LAL) assay detection limits and recirculation of parenteral products through endotoxin removal filters to allow batch release.

Hydrofil HTZ filters are highly resistant to integrity failure caused by steam sterilization or autoclave cycles and have excellent chemical compatibility characteristics.

Porvair’s sterilizing grade cartridges are integrity tested, with each individual module’s value recorded to ensure product safety.

The materials of construction are approved by the Federal Drug Administration (FDA) and meet the standards of the United States Pharmacopeia Class VI (USP VI).

Porvair Filtration Group has over 25 years experience in providing innovative solutions that meet the customer’s requirements as well as standards set by regulatory authorities.

Manufacturing of Porvair’s high performance, cost effective products is underpinned by a quality assurance programme, cGMP practices and clean room environment to ensure products meet the stringent requirements of the Pharmaceutical, Generics and Veterinary Medicines industry.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Porvair Expands Its Operations at New Milton
Expansion to provide manufacturing capacity to support future growth of the business.
Thursday, February 13, 2014
Contract Design, Manufacture and Assembly of Regulatory Compliant Polymer Products
Porvair Filtration Group has opened a new Class 100000 clean room facility at its Wrexham, UK site.
Friday, March 12, 2010
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos